Showing 2041-2050 of 8720 results for "".
Blue Light: A Different Take
https://practicaldermatology.com/topics/acne-rosacea/blue-light-a-different-take/20088/Targeted blue light can have beneficial effects on the skin, says Terrence Keaney, MD. He discusses the types of questions he gets from patients about blue light and what the current data show about the efficacy of low-energy at-home blue light treatments, particularly for acne.Six simple tips for an excellent dermatology website design
https://practicaldermatology.com/topics/practice-management/six-simple-tips-for-an-excellent-dermatology-website-design/20068/Is your website design outdated? Are you dreading the redesign? If so, check out this short video from Ekwa Marketing (www.ekwa.com) for tips on making the most of your redesign.Acne Treatment Strategies
https://practicaldermatology.com/conferences/maui-derm-2022/acne-treatment-strategies/20046/Guy F. Webster, MD, PhD shares acne management strategies that are effective for patients and help minimize use of antibiotics. He also discusses the continued role for isotretinoin for the right candidates.Advances in Wound Care
https://practicaldermatology.com/conferences/maui-derm-2022/maui-derm-2022-video/20040/Robert S. Kirsner, MD, PhD discusses the latest in wound healing science and resulting changes in how leading wound care experts are approaching patient care. From innovative products to greater understanding of the science, there are many options to help patients heal.DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with Avit5 Year Plan: Innovation Update
https://practicaldermatology.com/conferences/asds-2021/5-year-plan-innovation-update/20024/Mat Avram, MD provides an update on newly approved technologies as well as some that could be in use in practice within the next five years to improve outcomes or increase safety.Find Your Niche
https://practicaldermatology.com/topics/practice-management/find-your-niche-1/20268/Learn what you’re good at and what you have a passion for and then start channeling your career and education in that direction, Hilary Baldwin, MD recommends. She says finding an area of focus and expertise is a key to finding satisfaction and happiness at work.DERM2021: An Engaging Learning Experience
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-an-engaging-learning-experience/19967/Joe Gorelick, MSN, FNP-BC, DEF President, is excited for this year’s DERM2021 NP/PA CME Conference that offers meaningful case studies presented by an advisory panel of dermatology nurse practitioners and physician assistants for an engaging learning experience.Understanding the Complex Circuitry of Inflammatory Cytokines That Contribute to Psoriasis Pathogenesis
https://practicaldermatology.com/topics/psoriasis/understanding-the-complex-circuitry-of-inflammatory-cytokines-that-contribute-to-psoriasis-pathogenesis/19944/Hear expert insights on the mechanism of disease to understand the intricate circuitry of inflammatory cytokines in psoriasis pathogenesis.Hidradenitis Suppurativa: A Prevalent "Rare" Disease
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-prevalent-rare-disease/19926/Beyond recognizing that hidradenitis suppurativa is far more prevalent than once believed, research has also elucidated disease mechanisms, comorbidities, and pain pathways. Haley Naik, MD provides important updates on this previously neglected disease.